{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:21:16Z","timestamp":1726446076158},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,15]]},"DOI":"10.7759\/cureus.69465","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T19:20:14Z","timestamp":1726428014000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes of Sickle Cell Disease Patients With Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Nationwide Analysis"],"prefix":"10.7759","author":[{"given":"Oluwasegun  M","family":"Akinti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal C","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temi","family":"Ediale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzammil","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry O","family":"Aiwuyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-02278-5","article-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","author":"Cappelli B","year":"2019","unstructured":"Cappelli B, Gluckman E, Ghanem K, et al.. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. Carreras E, Dufour C, Mohty M (ed): Springer, 2019. 10.1007\/978-3-030-02278-5"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz217","article-title":"Cardiovascular manifestations of sickle cell disease","volume":"41","author":"Hammoudi N","year":"2020","unstructured":"Hammoudi N, Lionnet F, Redheuil A, Montalescot G. Cardiovascular manifestations of sickle cell disease. Eur Heart J. 2020, 41:1365-73. 10.1093\/eurheartj\/ehz217","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2020.02.002","article-title":"Cardiovascular complications of sickle cell disease","volume":"31","author":"Sachdev V","year":"2021","unstructured":"Sachdev V, Rosing DR, Thein SL. Cardiovascular complications of sickle cell disease. Trends Cardiovasc Med. 2021, 31:187-93. 10.1016\/j.tcm.2020.02.002","journal-title":"Trends Cardiovasc Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001112","article-title":"Management of acute coronary syndrome in the older adult population: a scientific statement from the American Heart Association","volume":"147","author":"Damluji AA","year":"2023","unstructured":"Damluji AA, Forman DE, Wang TY, et al.. Management of acute coronary syndrome in the older adult population: a scientific statement from the American Heart Association. Circulation. 2023, 147:e32-62. 10.1161\/CIR.0000000000001112","journal-title":"Circulation"},{"key":"ref5","unstructured":"Agency for Healthcare Research and Quality, Rockville. HCUP Databases. Healthcare Cost and Utilization Project (HCUP). (2024). Accessed. 25 May 2024: https:\/\/www.ahrq.gov\/data\/hcup\/index.html."},{"key":"ref6","unstructured":"World Health Organization (WHO). International Classification of Diseases (ICD). (2022). Accessed.  25 May 2024: http:\/\/www.who.int\/standards\/classifications\/classification-of-diseases."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.06.899","article-title":"The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: results from the TERCET registry with 19,781 individuals","volume":"288","author":"Dyrbu\u015b K","year":"2019","unstructured":"Dyrbu\u015b K, G\u0105sior M, Desperak P, et al.. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: results from the TERCET registry with 19,781 individuals. Atherosclerosis. 2019, 288:33-41. 10.1016\/j.atherosclerosis.2019.06.899","journal-title":"Atherosclerosis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/HPC.0b013e3181668ac3","article-title":"Acute myocardial infarction in sickle cell disease: a systematic review","volume":"7","author":"Pannu R","year":"2008","unstructured":"Pannu R, Zhang J, Andraws R, Armani A, Patel P, Mancusi-Ungaro P. Acute myocardial infarction in sickle cell disease: a systematic review. Crit Pathw Cardiol. 2008, 7:133-8. 10.1097\/HPC.0b013e3181668ac3","journal-title":"Crit Pathw Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.14744\/ejmi.2018.76486","article-title":"Risk factors of acute myocardial infarction: a review","volume":"2","author":"Rathore V","year":"2018","unstructured":"Rathore V. Risk factors of acute myocardial infarction: a review. Eur J Med Invest. 2018, 2:1-7. 10.14744\/ejmi.2018.76486","journal-title":"Eur J Med Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baz125","article-title":"MIRKB: a myocardial infarction risk knowledge base","volume":"2019","author":"Zhan C","year":"2019","unstructured":"Zhan C, Shi M, Wu R, He H, Liu X, Shen B. MIRKB: a myocardial infarction risk knowledge base. Database (Oxford). 2019, 2019:baz125. 10.1093\/database\/baz125","journal-title":"Database (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.15420\/icr.2019.09","article-title":"Outcomes after percutaneous coronary intervention in women: are there differences when compared with men?","volume":"14","author":"Rao U","year":"2019","unstructured":"Rao U, Buchanan GL, Hoye A. Outcomes after percutaneous coronary intervention in women: are there differences when compared with men?. Interv Cardiol. 2019, 14:70-5. 10.15420\/icr.2019.09","journal-title":"Interv Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/hearts5020016","article-title":"The impact of sickle cell disease on acute coronary syndrome and PCI outcomes: a retrospective observational study","volume":"5","author":"Alharbi A","year":"2024","unstructured":"Alharbi A, Pena C, Mhanna M, et al.. The impact of sickle cell disease on acute coronary syndrome and PCI outcomes: a retrospective observational study. Hearts. 2024, 5:236-45. 10.3390\/hearts5020016","journal-title":"Hearts"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278137","article-title":"Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance-a retrospective cohort study","volume":"17","author":"Ramsey SD","year":"2022","unstructured":"Ramsey SD, Bender MA, Li L, Johnson KM, Jiao B, Devine B, Basu A. Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance-a retrospective cohort study. PLoS One. 2022, 17:e0278137. 10.1371\/journal.pone.0278137","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003171","article-title":"Excessively high hydration volume may not be associated with decreased risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with renal insufficiency","volume":"5","author":"Liu Y","year":"2016","unstructured":"Liu Y, Li H, Chen S, et al.. Excessively high hydration volume may not be associated with decreased risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with renal insufficiency. J Am Heart Assoc. 2016, 5:e003171. 10.1161\/JAHA.115.003171","journal-title":"J Am Heart Assoc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1805256","article-title":"Contrast-associated acute kidney injury","volume":"380","author":"Mehran R","year":"2019","unstructured":"Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med. 2019, 380:2146-55. 10.1056\/NEJMra1805256","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.05.074","article-title":"Post-PCI acute heart failure is an independent predictor of long-term mortality in patients with chronic kidney disease","volume":"320","author":"Guo Z","year":"2020","unstructured":"Guo Z, Liu J, Sun G, et al.. Post-PCI acute heart failure is an independent predictor of long-term mortality in patients with chronic kidney disease. Int J Cardiol. 2020, 320:119-23. 10.1016\/j.ijcard.2020.05.074","journal-title":"Int J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.727727","article-title":"Incident heart failure in patients with coronary artery disease undergoing percutaneous coronary intervention","volume":"8","author":"Gu J","year":"2021","unstructured":"Gu J, Yin ZF, Xu ZJ, Fan YQ, Wang CQ, Zhang JF. Incident heart failure in patients with coronary artery disease undergoing percutaneous coronary intervention. Front Cardiovasc Med. 2021, 8:727727. 10.3389\/fcvm.2021.727727","journal-title":"Front Cardiovasc Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5791295","article-title":"Prognostic significance of percutaneous coronary intervention for first acute myocardial infarction with heart failure: five-year follow-up results","volume":"2022","author":"Cheng Z","year":"2022","unstructured":"Cheng Z, Shi Y, Peng H, Zhao D, Fan Q, Liu J. Prognostic significance of percutaneous coronary intervention for first acute myocardial infarction with heart failure: five-year follow-up results. Cardiol Res Pract. 2022, 2022:5791295. 10.1155\/2022\/5791295","journal-title":"Cardiol Res Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2019.05.003","article-title":"Total and cause-specific mortality after percutaneous coronary intervention: observations from the Alberta provincial project for outcome assessment in Coronary Heart Disease Registry","volume":"1","author":"Tran DT","year":"2019","unstructured":"Tran DT, Barake W, Galbraith D, et al.. Total and cause-specific mortality after percutaneous coronary intervention: observations from the Alberta provincial project for outcome assessment in Coronary Heart Disease Registry. CJC Open. 2019, 1:182-9. 10.1016\/j.cjco.2019.05.003","journal-title":"CJC Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1297527","article-title":"Predicting long-term prognosis after percutaneous coronary intervention in patients with acute coronary syndromes: a prospective nested case-control analysis for county-level health services","volume":"10","author":"Lu Y","year":"2023","unstructured":"Lu Y, Wang Y, Zhou B. Predicting long-term prognosis after percutaneous coronary intervention in patients with acute coronary syndromes: a prospective nested case-control analysis for county-level health services. Front Cardiovasc Med. 2023, 10:1297527. 10.3389\/fcvm.2023.1297527","journal-title":"Front Cardiovasc Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.02.052","article-title":"Prognostic value of microvascular resistance reserve after percutaneous coronary intervention in patients with myocardial infarction","volume":"82","author":"Eerdekens R","year":"2024","unstructured":"Eerdekens R, El Farissi M, De Maria GL, et al.. Prognostic value of microvascular resistance reserve after percutaneous coronary intervention in patients with myocardial infarction. J Am Coll Cardiol. 2024, 82:2066-76. 10.1016\/j.jacc.2024.02.052","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023276","article-title":"Long-term outcomes and clinical predictors of mortality following occurrence of stent thrombosis","volume":"11","author":"Ishihara T","year":"2022","unstructured":"Ishihara T, Okada K, Kida H, et al.. Long-term outcomes and clinical predictors of mortality following occurrence of stent thrombosis. J Am Heart Assoc. 2022, 11:e023276. 10.1161\/JAHA.121.023276","journal-title":"J Am Heart Assoc"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: incidence and predictors","volume":"8","author":"Jen\u010da D","year":"2021","unstructured":"Jen\u010da D, Melenovsk\u00fd V, Stehlik J, et al.. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 2021, 8:222-37. 10.1002\/ehf2.13144","journal-title":"ESC Heart Fail"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5660","article-title":"In-hospital outcomes and characteristics of heart failure in sickle cell disease","volume":"11","author":"Fadiran O","year":"2019","unstructured":"Fadiran O, Balogun AF, Ogunti R, et al.. In-hospital outcomes and characteristics of heart failure in sickle cell disease. Cureus. 2019, 11:e5660. 10.7759\/cureus.5660","journal-title":"Cureus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009690","article-title":"Sickle cell disease, interleukin-18, and arrhythmias","volume":"137","author":"Zhabyeyev P","year":"2021","unstructured":"Zhabyeyev P, Oudit GY. Sickle cell disease, interleukin-18, and arrhythmias. Blood. 2021, 137:1138-9. 10.1182\/blood.2020009690","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/277091-clinical-outcomes-of-sickle-cell-disease-patients-with-myocardial-infarction-undergoing-percutaneous-coronary-intervention-a-nationwide-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T19:20:19Z","timestamp":1726428019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/277091-clinical-outcomes-of-sickle-cell-disease-patients-with-myocardial-infarction-undergoing-percutaneous-coronary-intervention-a-nationwide-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,15]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.69465","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,15]]}}}